Ausgabe 9/2017
Inhalt (13 Artikel)
High-dose-rate brachytherapy as salvage modality for locally recurrent prostate cancer after definitive radiotherapy
Georgios Chatzikonstantinou, Nikolaos Zamboglou, Claus Rödel, Eleni Zoga, Iosif Strouthos, Saeed Ahmed Butt, Nikolaos Tselis
Defining biochemical recurrence after radical prostatectomy and timing of early salvage radiotherapy
Lars Budäus, Jonas Schiffmann, Markus Graefen, Hartwig Huland, Pierre Tennstedt, Alessandra Siegmann, Dirk Böhmer, Volker Budach, Detlef Bartkowiak, Thomas Wiegel
Dosimetric implications of inter- and intrafractional prostate positioning errors during tomotherapy
Peter Wust, Marc Joswig, Reinhold Graf, Dirk Böhmer, Marcus Beck, Thomasz Barelkowski, Volker Budach, Pirus Ghadjar
125I brachytherapy in younger prostate cancer patients
Isabelle Kindts, Karin Stellamans, Ignace Billiet, Hans Pottel, Antoon Lambrecht
Does combination therapy with tamsulosin and trospium chloride improve lower urinary tract symptoms after SEEDS brachytherapy for prostate cancer compared with tamsulosin alone?
Miao Yan, Peng Xue, Kunpeng Wang, Guojun Gao, Wei Zhang, Fanghu Sun
Impact of a rectal and bladder preparation protocol on prostate cancer outcome in patients treated with external beam radiotherapy
A. Maggio, D. Gabriele, E. Garibaldi, S. Bresciani, E. Delmastro, A. Di Dia, A. Miranti, M. Poli, T. Varetto, M. Stasi, P. Gabriele
Hyperfractionated accelerated radiation therapy plus cetuximab plus cisplatin chemotherapy in locally advanced inoperable squamous cell carcinoma of the head and neck
Thomas Kuhnt, Andreas Schreiber, Anett Pirnasch, Matthias G. Hautmann, Peter Hass, Frank P. Sieker, Rita Engenhart-Cabillic, Michael Richter, Kathrin Dellas, Jürgen Dunst
Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma
Milda Rudzianskiene, Arturas Inciura, Rolandas Gerbutavicius, Viktoras Rudzianskas, Andrius Macas, Renata Simoliuniene, Ruta Dambrauskiene, Greta Emilia Kiavialaitis, Elona Juozaityte
An IGRT margin concept for pelvic lymph nodes in high-risk prostate cancer
M. Groher, P. Kopp, M. Drerup, H. Deutschmann, F. Sedlmayer, Frank Wolf
A clinical example of extreme dose exposure for an implanted cardioverter–defibrillator
Yoana Hristova, Janett Köhn, Stefanie Preuß, Claus Rödel, Panagiotis Balermpas
Optimales Fraktionierungsschema und Zeitintervall zwischen Radiotherapie und Operation beim Rektumkarzinom
Emmanouil Fokas, Claus Rödel
Radiotherapie verstärkt Wirkung von PD-1-Checkpoint-Inhibitoren
René Baumann, Jürgen Dunst
Keine gesicherte Evidenz für strahleninduzierte Tumoren nach intrakranieller Radiochirurgie
Clemens Seidel, Rolf-Dieter Kortmann